JPRN-UMIN000004586招募中2 期
A phaseII randomized trial of UFT for the patients completely resected pathological Breast cancer - A phaseII randomized trial of UFT for the patients completely resected pathological Breast cancer Ryukyu Breast club 002 study
Ryukyu Breast Club0 个研究点目标入组 140 人开始时间: 2010年11月19日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. HER2 positive 2. Severe complications (uncontrolled diabetes mellitus, infection, heart failure which needs medical treatment (unstable angina pectoris, history of myocardial infarction occurred within 6 months), mental disorder) 3. Interstitial lung disease, pulmonary fibrosis 4. History of serious drug allergy 5. Active other malignancies 6. During pregnancy or lactation. 7. Patients judged inappropriate by physicians
研究者
相似试验
招募中
2 期
Randomized phase II study with UFT capsule /LV or UFT E-granule /LV adjuvant chemotherapy for patients with completely resected high-risk stage II and III colorectal cancercolorecrtal cancerJPRN-UMIN000010980HORE120
已完成
不适用
Phase I randomized study of 0.15% UF-021 in patients with geographic atrophy treated after wet age-related macular degeneratioAge-related macular degeneraitonJPRN-UMIN000007881Dept. of Ophthalmology, Kagawa university faculty of medicine50
已完成
2 期
Continued use of Atorvostatin in sepsisSepsis / infection in patients taking statin therapyBlood - Studies of infection and infectious agentsACTRN12605000756628Dr Peter Kruger, Intensive Care Specialist, Princess Alexandra Hospital, Brisbane200
已完成
不适用
A randomized phase II study of UFT/LV or TEGAFOX for patient with curatively resected high risk Stage II and Stage III colorectal cancer.high risk stage II/ stage III colorectal cancerJPRN-UMIN000007696Chiba surgical oncology development association200
已完成
2 期
Randomized phase II study of clinical effect of ultrasonically activated coagulating shears (Harmonic scalpel) for open gastrectomy.Gastric cancerJPRN-UMIN000003303Multicenter Clinical Study Group of Osaka (MCSGO)230